Bioinnovation

Embed Size (px)

Citation preview

BY SALMAN KHAN SHIVAM GUPTA NITIN TALREJA

PROBLEM

CASES OBSERVED

PRESENT COST FOR DIAGNOSIS

CURRENT TECHNIQUE

BLOOD SAMPLE

BLOOD SAMPLEBLOOD SAMPLE

Elecsys 2010

ELISA

DOWNSIDES OF THE PRESENT TECHNIQUE

OUR PROPOSAL

THE PROCESS INVOLVED

ANTICOAGULANT-BLOOD- PLASMA FILTERATION-ANTIGEN ANTIBODY REACTION- REACTION WITH CHROMOGENIC SUBSTRATE(TMB)-DEVELOPMENT OF BULE COLOUR-SPECTROPHOTOMETRIC ANALYSIS

CHANNELS AND CHIP DESIGN

BLOOD

HEPARIN

MIXING

(ST) COATING ALONG WITH ANTI TSH

FITERATION

SERUM

T.M.B

ACID COATED

ANTICOAGULANT-BLOOD- PLASMA FILTERATION-ANTIGEN ANTIBODY REACTION- REACTION WITH CHROMOGENIC SUBSTRATE(TMB)-DEVELOPMENT OF BULE COLOUR-SPECTROPHOTOMETRIC ANALYSIS

SALIENT FEATURE

POINT OF CARE DEVICE

AFFORDABLE

INSTANT RESULTS.

LESS ERROR.

MARKETING AND PROFIT CONCERNS

AFFORDABLE FOR SMALL CLINICS.

BETTER PROCESS CONTROL BECAUSE OF A FASTER RESPONSE OF THE SYSTEM

AFFORDABLE FOR GENERAL PUBLIC.

IT WILL INCREASE CURIOUSITY AMONG PEOPLE HENCE WILL HAVE BETTER MARKET.